No. Mounjari is a personal tracking and organization tool. It is not a medical device and does not provide diagnosis, treatment, or medical decisions.
Frequently asked questions
Short answers about how Mounjari works, where your data stays, and what the app does not do.
You can track weekly or daily GLP‑1 medications, including tirzepatide, semaglutide, liraglutide, dulaglutide, and retatrutide, or add a custom medication and dose.
No. The current version tracks one active medication. You can change the medication from settings, and the app keeps previous history.
Yes. Mounjari supports daily medications such as Rybelsus and weekly medications, with default frequency adjusted by medication type.
Yes. Mounjari has a full iPad app and an Apple Watch app, plus Home Screen widgets and an iOS Live Activity for fasting timers after some daily pills.
The app helps with reminders, but delivery depends on iOS or Android notification permissions, Focus or Do Not Disturb settings, battery optimization, and the device. Do not rely on reminders alone for important decisions.
No. Charts are approximate and educational, based on published models. They should not be used to change or stop a dose without your doctor.
Health data is stored on your device. On iOS, if you enable iCloud, sync happens through your own Apple account. On Android, Mounjari does not create a cloud account.
No. We do not sell personal or health data and do not share it for advertising.
No. Mounjari is not affiliated with any pharmaceutical company or medical product. Medication and active-ingredient names are used only to match what users record.
Use the support page to send your request. We will reply by email when we have enough detail.